<?xml version="1.0" encoding="utf-8" standalone="yes" ?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>GAPG Van Mastrigt, LT Burgers, WM Bramer, HJM Majoie, SMAA Evers, J Kleijnen on data_fR@</title>
    <link>/authors/gapg-van-mastrigt-lt-burgers-wm-bramer-hjm-majoie-smaa-evers-j-kleijnen/</link>
    <description>Recent content in GAPG Van Mastrigt, LT Burgers, WM Bramer, HJM Majoie, SMAA Evers, J Kleijnen on data_fR@</description>
    <generator>Hugo -- gohugo.io</generator>
    <language>en-us</language>
    <lastBuildDate>Mon, 01 Jan 2018 00:00:00 +0200</lastBuildDate>
    
	<atom:link href="/authors/gapg-van-mastrigt-lt-burgers-wm-bramer-hjm-majoie-smaa-evers-j-kleijnen/index.xml" rel="self" type="application/rss+xml" />
    
    
    <item>
      <title>How to prepare a systematic review of economic evaluations for clinical practice guidelines: database selection and search strategy development (part 2/3)</title>
      <link>/publication/sr-ee/</link>
      <pubDate>Mon, 01 Jan 2018 00:00:00 +0200</pubDate>
      
      <guid>/publication/sr-ee/</guid>
      <description>An Evidence Review Group Evaluation of the NICE Single Technology Appraisal for obinutuzumab in combination with chemotherapy for first-line treatment of advanced follicular lymphoma.</description>
    </item>
    
  </channel>
</rss>